Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2

Conditions

Febrile Neutropenia 6Neoplasms 4Neutropenia 2Hematologic Neoplasms 2Fever 2Sepsis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Emergencies 1

Interventions

ceftolozane, tazobactam drug combination 2Meropenem 2Itraconazole 2rasburicase 1pegylated granulocyte colony-stimulating factor 1pegaspargase 1fludarabine phosphate 1fludarabine 1eltrombopag 1drotrecogin alfa activated 1dexamethasone 21-phosphate 1Voriconazole 1Vancomycin 1Uric Acid 1Urate Oxidase 1Tropisetron 1Teicoplanin 1Solutions 1Ribavirin 1Pegloticase 1Oxidoreductases 1Ofloxacin 1Micafungin 1Metronidazole 1Imatinib Mesylate 1Hydromorphone 1Human Papillomavirus Recombinant Vaccine nonavalent 1Dexamethasone 1Dasatinib 1Ciprofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Hematologic Neoplasms × Meropenem × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT02149329 2019-09-25

SHORT

Amsterdam UMC, location VUmc

Phase 4 Completed
276 enrolled
Classical hematologyOther hematologic neoplasm

Fever, Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡